Use of Agilent’s Newly Released MassHunter Based Designer Drug GC/MS Library to the Identification of Seized Designer Drugs [Agilent]Lisa Malette
Designer drugs are widely recognized as a threat to public health and safety. Legislation continues to be enacted to limit their manufacture and distribution. Enforcement of legislation requires the ability to confirm the identity of a scheduled drug. One of the primary challenges associated with designer drugs is the availability of reference standards. As a result, mass spectral libraries have increased in importance as a means of qualitative identification of these compounds.
Agilent has just introduced a new GC/MS MassHunter based designer drug library containing over 300 drugs and their metabolites. This webinar will demonstrate the utility of this library as an additional tool to help in the identification of seized drugs from authentic case samples analyzed in the Sao Paulo State Scientific Police, in Sao Paulo, Brazil, and how it can also assist the national health surveillance authority in scheduling new drugs.
Price: Funding for this course has been provided by Agilent Technologies
Course Type: On-Demand Presentation
Section: Forensic sciences, Forensic technology, Forensic toxicology
Length: Approximately 50 minutes
Audience: Forensic Professionals and Practitioners
Course Accreditation: Certificate of Attendance